Dalbergin
Dalbergin exhibits similar bone conserving effect against bone-loss as estradiol treatment, it as a therapeutic candidate against postmenopausal osteoporosis.
Product Specifications
CAS Number
482-83-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
268.26
Molecular Formula
C16H12O4
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog